Case ReportPublished 9 October 2026Extensive vulvar and perianal langerhans cell histiocytosis with clinical improvement during low-dose thalidomide and topical therapy: a case reportPan Zou · Xiao Mei ZhuFrontiers in Medicinedoi 10.3389/fmed.2026.1969330
Case ReportPublished 9 October 2026Case Report: Ribociclib-associated bilateral neurotrophic keratitis requiring amniotic membrane transplantation during adjuvant treatment of early breast cancerDanielle DeCicco · Sanjana Nethagani · Lingo Lai · Danish SafiFrontiers in Oncologydoi 10.3389/fonc.2026.1932226
ReviewPublished 8 October 2026Therapeutic potential of Boswellia -derived compounds in skin conditionsEman A. Alturki · Caroline S. Weckerle · Caroline Maake · Raha Orfali · Michael HeinrichFrontiers in Pharmacologydoi 10.3389/fphar.2026.1966705
Case ReportPublished 18 September 2026Case Report: Multisystem response to dupilumab in a child with atopic dermatitis, asthma, eosinophilic esophagitis, and other gastrointestinal manifestationsHua-Jie Yan · Wei Dong · Yu-Nan Yang · Chun-Yun ZengFrontiers in Allergydoi 10.3389/falgy.2026.1929466
Brief Research ReportPublished 27 July 2026Optimised mesalazine therapy reduces ulcerative colitis recurrence across the mild-to-moderate disease spectrum: the IMPACT studyBolette Christophersen · John Fullarton · Rachel WestFrontiers in Gastroenterologydoi 10.3389/fgstr.2026.1874051
Science archivePublished 9 July 2025Real-world safety and effectiveness of dupilumab for the treatment of atopic dermatitis: two-year post-marketing surveillance in JapanHidehisa Saeki · Makiko Usami · Katsuhisa Suzuki · Michika Mochizuki · Kazuhiko ArimaJournal of Cutaneous Immunology and Allergydoi 10.3389/jcia.2025.14794
